@jcrabapple finally a chance for billionaires to shine.

"The cure for sickle cell disease now exists.

For a large proportion of the people who need it most, it remains entirely out of reach.

Lyfgenia carries a list price of $3.1 million. Casgevy lists for $2.2 million."